Inhibition of p38-MK2 pathway enhances the efficacy of microtubule inhibitors in breast cancer cells
Yu‐Chia Chen, Mamoru Takada, Aerica Nagornyuk…·Aussie Suzuki
This study shows that inhibiting the p38-MK2 pathway enhances the effectiveness of microtubule inhibitors in breast cancer cells while sparing normal cells.